FDA inspection
Janssen Pharmaceuticals, Inc.: FDA inspection ending Oct 15, 1999
FDA inspection 1101 · No Action Indicated (NAI) · Raritan, NJ
Key facts
| Inspection ID | 1101 |
|---|---|
| Firm | Janssen Pharmaceuticals, Inc. |
| FEI number | 2211100 |
| Address | 1000 US Highway 202 |
| City | Raritan |
| State | NJ |
| ZIP | 08869-1425 |
| Fiscal year | 2000 |
| Inspection end date | Oct 15, 1999 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data